Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems

被引：11

作者：

Akturk, Halis K. ^{[1
]}

Battelino, Tadej ^{[2
,3
]}

Castaneda, Javier ^{[4
]}

Arrieta, Arcelia ^{[4
]}

van den Heuvel, Tim ^{[4
]}

Cohen, Ohad ^{[4
]}

机构：

[1] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA

[2] Univ Ljubljana, Univ Med Ctr Ljubljana, Ljubljana, Slovenia

[3] Univ Ljubljana, Fac Med, Ljubljana, Slovenia

[4] Medtron Int Trading Sarl, Route Molliau 31, CH-1131 Tolochenaz, Switzerland

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2024年 / 26卷

关键词：

Automated insulin delivery; Time in tight range; Insulin therapy; Closed-loop; Insulin pump; MiniMed (TM); Glucose control; INTERNATIONAL CONSENSUS; DIABETIC-RETINOPATHY; METRICS; COMPLICATIONS; ASSOCIATION; INITIATION;

D O I：

10.1089/dia.2023.0432

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The concept of maintaining blood glucose levels within the 70-180 mg/dL range, known as time-in-range, has raised questions regarding its representation of true physiological euglycemia. Some have speculated that focusing on the time spent within the 70-140 mg/dL range, introduced as time in tight range (TITR) through the International Consensus statement, could serve as a more precise metric for assessing normoglycemia in individuals with type 1 diabetes. This article delves into the current status of TITR as an emerging marker and explores how advanced hybrid closed-loop systems may offer a promising avenue for achieving this higher level of glycemic control.

引用

页码：102 / 106

页数：5

共 50 条

[21] Glucose-Responsive Synthetic Closed-Loop Insulin Delivery Systems
Zhang Yuqi
Yu Jicheng
Shen Qundong
Gu Zhen
PROGRESS IN CHEMISTRY, 2015, 27 (01) : 11 - 26
[22] Feasibility Study of a Hybrid Closed-Loop System with Automated Insulin Correction Boluses
Nimri, Revital
Grosman, Benyamin
Roy, Anirban
Nir, Judith
Fisch Shvalb, Naama
Kurtz, Natali
Loewenthal, Neta
Gillon-Keren, Michal
Muller, Ido
Atlas, Eran
Phillip, Moshe
DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (04) : 268 - 276
[23] Closed-loop insulin delivery: current status of diabetes technologies and future prospects
Majeed, Waseem
Thabit, Hood
EXPERT REVIEW OF MEDICAL DEVICES, 2018, 15 (08) : 579 - 590
[24] Real-World Implementation of Hybrid Closed-Loop (HCL) Insulin Delivery
Faulds, Eileen R.
Dungan, Kathleen M.
DIABETES, 2018, 67
[25] Minimed 670G: A Hybrid Closed-Loop Insulin Delivery System
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1508): : 147 - 148
[26] The importance of prandial insulin bolus timing with hybrid closed-loop systems
Boughton, C. K.
Hartnell, S.
Allen, J. M.
Hovorka, R.
DIABETIC MEDICINE, 2019, 36 (12) : 1716 - 1717
[27] Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy
Renard, E
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (06) : 708 - 716
[28] Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system
Panteleon, Antonios E.
Loutseiko, Mikhail
Steil, Garry M.
Rebrin, Kerstin
DIABETES, 2006, 55 (07) : 1995 - 2000
[29] Experiences of Patients Adopting and Adapting to Closed-Loop Insulin Delivery Systems (CLIDS)
Manero, Chrystina
SCIENCE OF DIABETES SELF-MANAGEMENT AND CARE, 2023, 49 (01): : 46 - 54
[30] Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes
Vikash Dadlani
Jordan E. Pinsker
Eyal Dassau
Yogish C. Kudva
Current Diabetes Reports, 2018, 18

← 1 2 3 4 5 →